Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine and Steroids in COVID-19 Pneumonia
NCT04540926Phase 2Unknown
- Sponsor
- ISSSTE
- Start
- Sep 2020
- Primary completion
- Sep 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in COVID-19 pneumonia, sponsored by ISSSTE. Status: unknown.
02
Drugs
cyclosporine
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04540926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04540926.